Colon Cancer

Colon cancer in brief

Colon cancer is a very common cancer in Germany. Cancer of the colon and rectum (colorectal carcinoma) is the second most common cancer in women and the third most common in men; around 55,000 people develop it every year, about two thirds of them in the colon. This article covers colon cancer, as distinct from cancer of the rectum. Men are affected somewhat more often than women. The median age at diagnosis is around 70 to 75 years. Mortality has been declining for years: today, about two thirds of those affected are still alive five years after diagnosis. In Germany, established screening examinations are available for colon cancer, which allow precancerous lesions to be removed before cancer develops.

Colon cancer at a glance

New cases in Germany
Around 55,000 per year with colorectal cancer, about two thirds of them in the colon
Typical age
Median of around 70 to 75 years
Survival
About two thirds of those affected are still alive five years after diagnosis
Screening
From age 50, entitlement to a colonoscopy, during which precancerous lesions can be removed

What exactly is colon cancer?

In this article, colorectal cancer refers to what is known as adenocarcinoma of the bowel, which arises from the glandular cells of the intestinal lining. It accounts for about 95 % of all colorectal cancers. Typically, colorectal cancer develops over many years from benign precursors (polyps or adenomas). This is called the adenoma-carcinoma sequence. That is why it is important to take part in screening: if polyps are removed during a colonoscopy, they can no longer turn into cancer. However, there are also other ways in which it can develop.

Why do I have colon cancer?

There is no specific cause for the development of colon cancer. However, a number of risk factors are known:

  • Certain hereditary conditions: These account for only about 3 to 5 % of all colon cancers. They include, for example, Lynch syndrome (HNPCC) and familial adenomatous polyposis (FAP).
  • Colon or rectal cancer in one or more first-degree relatives, especially if the disease occurred before the age of 50
  • Inflammatory bowel diseases: ulcerative colitis and Crohn's disease, especially when they have been present for many years

There are also known lifestyle factors that favor colon cancer:

  • Smoking and high alcohol consumption
  • Diet: low in fiber, high in fat, with a high proportion of red meat and processed meats and a low proportion of vegetables and fruit
  • Overweight and lack of exercise

Although these factors can increase the risk, this does not mean that every person with these risk factors will inevitably develop colon cancer.

Symptoms of colon cancer

In early stages, there are often no symptoms. Possible complaints are:

  • Blood in the stool: The blood can turn the stool dark or may only be detectable in a stool test; the resulting blood loss (anemia) is often the first sign
  • Changes in bowel habits: Both diarrhea and constipation can occur, including alternating between the two
  • Abdominal pain, cramps
  • Bowel obstruction (ileus): when the colon cancer completely blocks the lumen, i.e. the inside of the bowel – an emergency

General symptoms such as unintended weight loss and a drop in performance can also occur.

Some of the symptoms are very nonspecific and can also occur with other diseases. That is why it is important to see a doctor if you notice any signs.

When is colon cancer treated?

Outside of screening, colon cancer is often only discovered at later stages. The diagnosis is confirmed by a colonoscopy with a tissue sample; computed tomography is then used to determine how far the disease has spread. In addition, molecular features are determined in the tumor tissue (e.g. RAS and BRAF mutations, microsatellite instability), because they determine which drugs will work. After that, the recommends a therapy that depends on the stage of the disease and other factors.

There is also an established screening program for colon and rectal cancer. In Germany, men and women aged 50 and over are entitled to a complete colonoscopy. If benign polyps are found, they are removed right away. If the colonoscopy is unremarkable, it is repeated after 10 years. Alternatively, from age 50, a stool test for hidden blood can be done (annually up to age 54, every two years after that). For people with a family history, screening starts earlier.

How is colon cancer treated?

The treatment of colon cancer is tailored to many factors, for example the disease stage and the molecular features of the tumor. This makes choosing the actual therapy complex. Possible treatment options include:

  • Surgical resection (removal): There are different surgical procedures. Usually, the affected section of the bowel is removed together with the associated lymph nodes in order to eliminate the colon cancer completely. In early stages, surgery alone is sufficient; in more advanced stages, it is followed by additional (adjuvant) chemotherapy after the operation. Individual (e.g. in the liver) can also be removed surgically.
  • Drug-based cancer therapy
    • Chemotherapy: Different drugs can be used here, usually in combination (e.g. FOLFOX or CAPOX).
    • Targeted therapy: In advanced disease, antibodies against the growth receptor EGFR or against the formation of new blood vessels (VEGF) are combined with chemotherapy – depending on the molecular features and the location of the tumor.
  • Immunotherapy: Checkpoint inhibitors, which help the immune system fight the cancer – they work very well in the small group of tumors with what is known as microsatellite instability (about 5 % of advanced cases). In addition, structured physical activity programs are useful, as they have been shown to lower the risk of relapse.

How exactly have clinical trials changed the treatment landscape for colon cancer?

A great deal of research has been done on the treatment of colon cancer, so that surgical treatment is increasingly being supplemented by drugs. Newer approaches also include molecularly targeted therapies. They can be used when a specific feature is present in the cancer cells. Major examples of trials are:

  • MOSAIC trial (2004/2009): Surgery is often followed by chemotherapy (adjuvant). This trial in 2,246 patients investigated adding oxaliplatin to the established chemotherapy with fluorouracil. It showed that this prolongs disease-free survival and that, in stage III, more patients are also cured. Chemotherapy recommendations have been adjusted since then.
  • IDEA collaboration (2018): A joint analysis of six trials with 12,834 patients investigated whether chemotherapy for 3 months is just as effective as the previously usual 6 months. It showed that for patients at lower risk, 3 months of the drug combination CAPOX is sufficient. Above all, this has the advantage of reducing side effects such as permanent nerve damage.

Newer trials make it possible to tailor therapy even more precisely.

  • FIRE-3 trial (2014): This German trial compared two treatment regimens in 592 patients with metastatic colorectal cancer: chemotherapy with the antibody cetuximab (against EGFR) or with the antibody bevacizumab (against the formation of new blood vessels). Later analyses together with other trials described an interesting phenomenon: what matters for treatment is on which side of the bowel – left or right – the tumor arose. Patients with left-sided colon cancer (without a RAS mutation) benefit considerably from antibody therapy against EGFR, whereas patients with a right-sided tumor hardly benefit. Since then, tumor location has been part of the treatment decision.

Interested in taking part in clinical trials? Then take a look here at the current trials in Germany.

This information is not a substitute for a conversation with your doctor.